Baby Safety / Compounds / Gabapentin

Is Gabapentin safe for babies and kids?

Moderate risk for kids

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Gabapentin poses heightened risk.

What is gabapentin?

The IUPAC name is 2-[1-(aminomethyl)cyclohexyl]acetic acid.

Also known as: 2-[1-(aminomethyl)cyclohexyl]acetic acid, Neurontin, Gabapentine, 1-(Aminomethyl)cyclohexaneacetic acid.

IUPAC name
2-[1-(aminomethyl)cyclohexyl]acetic acid
CAS number
60142-96-3
Molecular formula
C9H17NO2
Molecular weight
171.24 g/mol
SMILES
C1CCC(CC1)(CC(=O)O)CN
PubChem CID
3446

Risk for babies

Moderate risk

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Gabapentin poses heightened risk.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Elevated risk

Gabapentin poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

4 regulatory and scientific bodies have classified Gabapentin. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA—Approved anticonvulsant (adjunctive therapy for partial-onset seizures)FDA-approved indication
FDA—Approved analgesic (postherpetic neuralgia, diabetic neuropathy)FDA-approved indication
FDA2019Respiratory depression risk warningWarning issued regarding respiratory depression risk with gabapentin in patients with respiratory risk factors and CNS depressant co-administration
US States—Schedule VScheduled in several US states due to abuse potential

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter gabapentin

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Gabapentin:

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is gabapentin safe for kids?

Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Gabapentin poses heightened risk.

What products contain gabapentin?

Gabapentin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to gabapentin?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about gabapentin?

Gabapentin has been classified by 4 agencies including FDA, FDA, FDA, US States, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Gabapentin in the baby app

Look up products containing gabapentin, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)
  1. US FDA: Gabapentin Prescribing Information — Indications, CNS Depression Warning, Respiratory Depression (2019 Drug Safety Communication), and Abuse Potential (2019) — regulatory
  2. ASPCA Animal Poison Control Center: Gabapentin Toxicosis in Dogs and Cats — Sedation, Ataxia, Excipient Concerns (Xylitol/Propylene Glycol), and Management (2023) — veterinary
  3. Plumb's Veterinary Drug Handbook (10th ed.) — Gabapentin: Veterinary Analgesia, Anxiolysis, Anticonvulsant Use, and Formulation Safety in Dogs and Cats (2023) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →